Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: A 10-year follow-up study

Haemophilia

Volumn 18, Issue 5, 2012, Pages 789-793

  Pardos Gea, J ^a   Altisent, C ^a   Parra, R ^a   Vilardell Tarres M ^a   Ordi Ros, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acquired haemophilia; Calcineurin inhibitors; Cyclosporine; Factor VIII inhibitor; Tacrolimus

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RITUXIMAB; TACROLIMUS;

ACQUIRED HAEMOPHILIA A; ACQUIRED HEMOPHILIA A; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; ENCEPHALOMYOPATHY; FEMALE; FOLLOW UP; HEMOPHILIA A; HUMAN; HYPERTENSION; HYPERTENSIVE POSTERIOR PROGRESSIVE ENCEPHALOPATHY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENESCENCE; SURVIVAL RATE; THERAPY EFFECT; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BLOOD COAGULATION FACTOR INHIBITORS; CALCINEURIN; CYCLOSPORINE; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84865566536     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02772.x     Document Type: Article

References (25)

1. Delgado J, Jimenez-Yuste V, Hernández-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
2. Bitting RL, Bent S, Li Y, Kolhwes J. The prognosis and treatment of acquired haemophilia: a systematic review and meta-analysis. Blood Coagul Fibrinolysis 2009; 20: 517-23.
3. Collins PW, Hirsch S, Baglin TP et al. Acquired haemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor's Organisation. Blood 2007; 109: 1870-7.
4. Marco P, Collins PW, Knoebl P et al. Acquired haemophilia: clinical and demographic data. Results of European Acquired Haemophilia Registry (EACH2). Blood 2010; 116: 1398.
5. Kasper CK, Aledort LM, Aronson D et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 612.
6. Green D, Lechner K. A survey of 215 non-haemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
7. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 2004; 124: 86-90.
8. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia: a natural study on 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Inter Med 1987; 147: 1077-81.
9. Collins PW, Baudo F, Knobl P et al. Inhibitor eradication in acquired haemophilia A: final results of European Acquired Haemophilia Registry (EACH2). Blood 2010; 116: 715.
10. Green D, Rademaker AW, Briet A. A prospective, randomized trial of predisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
11. Sperr WR, Lechner K, Pabinger I. Rituximab for the treatment of acquired antibodies to factor VIII. Haematologica 2007; 92: 66-71.
12. Collins PW. Management of acquired haemophilia A. J Thromb Haemost 2011; 9(Suppl. 1): 226-35.
13. Aouba A, Rey G, Pavillon G et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: mutiple cause analysis for best care strategies. Haemophilia 2011; Sept 13. Epub ahead of print.
14. Pardos-Gea J, Ordi-Ros J, Altisent C, Balada E, Perez-Lopez J, Vilardell M. Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporine. Thromb Haemost 2006; 95: 735-7.
15. Hart HC, Kraijenhagen RJ, Kerckhaert JAM, Verdel G, Freen M, van de Wiel A. A patient with spontaneous factor VIII:C autoantibody:successful treatment with cyclosporine. Transplant Proc 1988; 20(Suppl. 4): 323-8.
16. Pflieger G, Boda Z, Harsfalvi J et al. Cyclosporine treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor. Postgrad Med J 1989; 65: 400-2.
17. Siegbahn A, Feltelius N, Norlen BJ et al. Treatment of acquired haemophilia due to FVIII:C auto antibodies with recombinant FVIIa and cyclosporin. Thromb Haemost 1995; 73: 1424.
18. McLeod BC, McKenna R, Chediak J. Treatment of acquired factor VIII inhibitors with antibody removal by aphresis followed by immunosuppression with prednisone and cyclosporine. Blood 1989; 74: 39.
19. Shulman S, Langevithz P, Livneh A, Mortinowitz U, Seligsohn U, Varon D. Cyclosporin therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost 1996; 76: 344-6.
20. Brox AG, Laryea H, Pelletier M. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol 1998; 57: 87-8.
21. Petrovic M, Derom E, Baele G. Cyclosporine treatment of acquired haemophilia due to factor VIII antibodies. Haematologica 2000; 85: 895-6.
22. Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M. Acquired haemophilia-a study of ten cases. Haemophilia 2000; 6: 78-83.
23. Wano Y, Kang Y, Masaki H et al. Cyclosporine A as an effective treatment for a patient with acquired hemophilia A complicated with diabetes mellitus and ischemic heart disease. Rinsho Ketsueki. 2005; 46: 1100-4.
24. Au WY, Lam CC, Kwong YL. Successful treatment of acquired factor FVIII inhibitor with cyclosporin. Haemophilia 2004; 10: 98-100.
25. Collins PW, Baudo F, Huth-Kuhne A et al. Firstline immunosuppressive treatment for acquired factor VIII antibodies: results of the European acquired haemophilia registry (EACH2). J Thromb Haemost 2009; 7: 609.